A case of fulminant myocarditis with full recovery after a 38‐h sustained asystole

Even if cardiac rhythm deteriorated to asystole in the clinical course of fulminant myocarditis, cardiac function may recover, and the patient may be discharged without brain damage, if circulation could be maintained by appropriate mechanical cardiac supports.

[1]  R. Leyh,et al.  Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation , 2022, Life.

[2]  J. Antaki,et al.  Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support. , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  A. Bayés‐Genís,et al.  Fulminant myocarditis in adults: a narrative review , 2022, Journal of geriatric cardiology : JGC.

[4]  P. Kurlansky,et al.  Clinical efficacy of direct or indirect left ventricular unloading during venoarterial extracorporeal membrane oxygenation for primary cardiogenic shock. , 2021, The Journal of thoracic and cardiovascular surgery.

[5]  L. Cooper,et al.  Recognition and Initial Management of Fulminant Myocarditis , 2020, Circulation.

[6]  Supriya Singh,et al.  Fatal influenza myocarditis with incessant ventricular tachycardia , 2019, BMJ Case Reports.

[7]  G. Veronese,et al.  Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment , 2018, Current Cardiology Reports.

[8]  E. Natour,et al.  Protracted aortic valve closure during peripheral veno-arterial extracorporeal life support: is intra-aortic balloon pump an effective solution? , 2018, Perfusion.

[9]  H. Vidula,et al.  Treatment of Acute Necrotizing Eosinophilic Myocarditis With Immunosuppression and Mechanical Circulatory Support , 2016, Circulation. Heart failure.

[10]  R. Kociol,et al.  Recovery of giant-cell myocarditis using combined cytolytic immunosuppression and mechanical circulatory support. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  R. Cheng,et al.  Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: a weighted meta-analysis of 170 patients. , 2014, Journal of cardiac failure.

[12]  V. Ruppert,et al.  Management of fulminant myocarditis: A diagnosis in search of its etiology but with therapeutic options , 2014, Current Heart Failure Reports.

[13]  N. Chi,et al.  Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis , 2008, The Lancet.

[14]  T. Sakamoto,et al.  Fulminant myocarditis survivor after 56 hours of non-responsive cardiac arrest successfully returned to normal life by cardiac resynchronization therapy: a case report. , 2006, Journal of cardiology.

[15]  R. Hruban,et al.  Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. , 2000, The New England journal of medicine.

[16]  Ryan P. Barbaro,et al.  Extracorporeal Life Support Organization Registry International Report 2016 , 2017, ASAIO journal.

[17]  Shu-Chien Huang,et al.  Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first? , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.